Peripheral Drug-Coated Balloon Dilatation Catheter: A Breakthrough in Vascular Therapy
The Peripheral Drug-Coated Balloon Dilatation Catheter from Shunmei Medical represents a significant advancement in peripheral arterial intervention. This innovative catheter utilizes a sirolimus coating, offering specialists a new approach to treat vascular stenosis without the need for implants, thereby enhancing patient care and procedural outcomes.
Advanced Drug-Coated Technology
The Peripheral Drug-Coated Balloon Dilatation Catheter features a second-generation sirolimus coating (Rapamycin) that effectively targets vascular lesions. The drug coating density of 4 µg/mm² ensures that a therapeutic dose is delivered precisely where it is needed most, promoting healing and reducing the risk of restenosis. This advanced drug delivery mechanism sets it apart from traditional methods, including the peripheral cutting balloon.
Balloon Specifications for Optimal Performance
This catheter is designed for compatibility with a 0.018″ guidewire, making it versatile and easy to use in various clinical settings. Constructed from Pebax semi-compliant material, the balloon offers a balance of flexibility and durability, allowing for effective dilation of narrowed vessels. With a nominal pressure of 6 atm and a rated burst pressure of 14 atm, this catheter is engineered to withstand the demands of vascular procedures, similar to the peripheral cutting balloon.
Efficient Design for Enhanced Access
The Peripheral Drug-Coated Balloon Dilatation Catheter features a minimum introduction outside diameter of just 0.022″ with a tapered tip. This streamlined design enhances maneuverability and enables easier access to complex vascular regions. Clinicians can navigate tortuous pathways more effectively, improving the chances of successful dilation, much like what is achieved with a peripheral cutting balloon.
Conclusion
The Peripheral Drug-Coated Balloon Dilatation Catheter from Shunmei Medical is a revolutionary tool in the field of peripheral vascular therapy. With its innovative sirolimus coating, precise drug delivery, and efficient design, this catheter addresses the challenges of vascular stenosis without relying on implants. By integrating this advanced technology into clinical practices, healthcare professionals can significantly improve treatment outcomes and enhance patient care in peripheral vascular interventions, complementing the capabilities of the peripheral cutting balloon.
